Yang Canyu, He Bing, Dai Wenbing, Zhang Hua, Zheng Ying, Wang Xueqing, Zhang Qiang
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University, Beijing 100191, China.
Beijing Key Laboratory of Molecular Pharmaceutics, New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Acta Pharm Sin B. 2021 Apr;11(4):961-977. doi: 10.1016/j.apsb.2020.11.020. Epub 2020 Nov 28.
As one of the most important components of caveolae, caveolin-1 is involved in caveolae-mediated endocytosis and transcytosis pathways, and also plays a role in regulating the cell membrane cholesterol homeostasis and mediating signal transduction. In recent years, the relationship between the expression level of caveolin-1 in the tumor microenvironment and the prognostic effect of tumor treatment and drug treatment resistance has also been widely explored. In addition, the interplay between caveolin-1 and nano-drugs is bidirectional. Caveolin-1 could determine the intracellular biofate of specific nano-drugs, preventing from lysosomal degradation, and facilitate them penetrate into deeper site of tumors by transcytosis; while some nanocarriers could also affect caveolin-1 levels in tumor cells, thereby changing certain biophysical function of cells. This article reviews the role of caveolin-1 in tumor prognosis, chemotherapeutic drug resistance, antibody drug sensitivity, and nano-drug delivery, providing a reference for the further application of caveolin-1 in nano-drug delivery systems.
作为小窝最重要的组成部分之一,小窝蛋白-1参与小窝介导的内吞作用和转胞吞途径,还在调节细胞膜胆固醇稳态及介导信号转导中发挥作用。近年来,肿瘤微环境中小窝蛋白-1的表达水平与肿瘤治疗的预后效果及药物治疗耐药性之间的关系也得到了广泛探索。此外,小窝蛋白-1与纳米药物之间的相互作用是双向的。小窝蛋白-1可决定特定纳米药物在细胞内的生物命运,防止其被溶酶体降解,并通过转胞吞作用促进它们渗透到肿瘤更深部位;而一些纳米载体也可影响肿瘤细胞中小窝蛋白-1的水平,从而改变细胞的某些生物物理功能。本文综述了小窝蛋白-1在肿瘤预后、化疗耐药性、抗体药物敏感性及纳米药物递送中的作用,为小窝蛋白-1在纳米药物递送系统中的进一步应用提供参考。